2019

• Andrey, D. O.et al. 2019. An emerging clone, KPC-2-producing Klebsiella pneumoniae ST16, associated with high mortality rates in a CC258 endemic setting. Clinical Infectious Diseases (10.1093/cid/ciz1095)
• Li, J.et al. 2019. Inter-host transmission of carbapenemase-producing escherichia coli among humans and backyard animals. Environmental Health Perspectives 127(10), article number: 107009. (10.1289/EHP5251)
• Kiddee, A.et al. 2019. Risk factors for extended-spectrum β-lactamase-producing Enterobacteriaceae carriage in patients admitted to Intensive Care Unit in a Tertiary Care Hospital in Thailand. Microbial Drug Resistance 25(8), pp. 1182-1190. (10.1089/mdr.2018.0318)
• Shen, Y.et al. 2019. Integrated aquaculture contributes to the transfer of mcr-1 between animals and humans via the aquaculture supply chain. Environment International 130, article number: 104708. (10.1016/j.envint.2019.03.056)
• Farzana, R.et al. 2019. Emergence of mcr-1 mediated colistin resistant Escherichia coli from a hospitalized patient in Bangladesh. Journal of Infection in Developing Countries 13(8), pp. 773-776. (10.3855/jidc.11541)
• Langley, G. W.et al. 2019. Profiling interactions of vaborbactam with metallo-β-lactamases. Bioorganic and Medicinal Chemistry Letters 29(15), pp. 1981-1984. (10.1016/j.bmcl.2019.05.031)
• Stewardson, A. J.et al. 2019. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. Lancet Infectious Diseases 19(6), pp. 601-610. (10.1016/S1473-3099(18)30792-8)
• Tansawai, U., Walsh, T. R. and Niumsup, P. R. 2019. Extended spectrum ß-lactamase-producing Escherichia coli among backyard poultry farms, farmers, and environments in Thailand. Poultry Science 98(6), pp. 2622-2631. (10.3382/ps/pez009)
• He, T.et al. 2019. Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans. Nature Microbiology (10.1038/s41564-019-0445-2)
• Qamar, M. U.et al. 2019. Dissemination of genetically diverse NDM-1, -5, -7 producing-Gram-negative pathogens isolated from pediatric patients in Pakistan. Future Microbiology 14(8) (10.2217/fmb-2019-0012)
• Farzana, R.et al. 2019. Outbreak of hypervirulent multi-drug resistant Klebsiella variicola causing high mortality in neonates in Bangladesh. Clinical Infectious Diseases 7, pp. 1225-1227. (10.1093/cid/ciy778)
• Juhas, M.et al. 2019. In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy 74(4), pp. 944-952. (10.1093/jac/dky546)
• Wang, Z.et al. 2019. Genetic environment of colistin resistance genes mcr-1 and mcr-3 in Escherichia coli from one pig farm in China. Veterinary Microbiology 230, pp. 56-61. (10.1016/j.vetmic.2019.01.011)
• Salimraj, R.et al. 2019. Crystal structures of VIM-1 complexes explain active site heterogeneity in VIM-class metallo-β-lactamases. FEBS Journal 286(1), pp. 169-183. (10.1111/febs.14695)
• Tyrrell, J. M.et al. 2019. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii. Peptides 112, pp. 149-153. (10.1016/j.peptides.2018.12.006)
• Yu, Y.et al. 2019. Novel partners with colistin to increase its in vivo therapeutic effectiveness and prevent the occurrence of colistin resistance in NDM- and MCR-co-producing Escherichia coli in a murine infection model. Journal of Antimicrobial Chemotherapy 74(14), pp. 87-95. (10.1093/jac/dky413)
• Yang, Q. E.et al. 2019. Environmental dissemination of mcr-1 positive Enterobacteriaceae by Chrysomya spp. (common blowfly): An increasing public health risk. Environment International 122, pp. 281-290. (10.1016/j.envint.2018.11.021)

2018

• Shen, Z.et al. 2018. Emerging carriage of NDM-5 and MCR-1 in Escherichia coli from healthy people in multiple regions in China: a cross sectional observational study. EClinicalMedicine 6, pp. 11-20. (10.1016/j.eclinm.2018.11.003)
• Qamar, M. U.et al. 2018. First identification of clinical isolate of a Novel “NDM-4” producing Escherichia coli ST405 from urine sample in Pakistan. Brazilian Journal of Microbiology 49(4), pp. 949-950. (10.1016/j.bjm.2018.02.009)
• Collignon, P.et al. 2018. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. The Lancet Planetary Health 2(9), pp. e398-e405. (10.1016/S2542-5196(18)30186-4)
• Walsh, T. R. 2018. A one-health approach to antimicrobial resistance. Nature Microbiology 3(8), pp. 854-855. (10.1038/s41564-018-0208-5)
• Shen, Y.et al. 2018. Anthropogenic and environmental factors associated with high incidence of mcr-1 carriage in humans across China. Nature Microbiology 3(9), pp. 1054-1062. (10.1038/s41564-018-0205-8)
• Li, H.et al. 2018. Molecular insights into functional differences between mcr-3- and mcr-1-mediated colistin resistance. Antimicrobial Agents and Chemotherapy, article number: AAC.00366. (10.1128/AAC.00366-18)
• Kiddee, A.et al. 2018. Risk factors for gastrointestinal colonization and acquisition of carbapenem-resistant gram-negative bacteria among patients in intensive care units in Thailand. Antimicrobial Agents and Chemotherapy 62(8), article number: e00341. (10.1128/AAC.00341-18)
• Zowawi, H. M.et al. 2018. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region. Journal of Medical Microbiology 67(6), pp. 846-853. (10.1099/jmm.0.000730)
• Yu, Y.et al. 2018. Combination therapy strategies against multiple-resistant streptococcus suis. Frontiers in Pharmacology 9, article number: 489. (10.3389/fphar.2018.00489)
• Yang, Q. E.et al. 2018. Heavy metal resistance genes are associated with blaNDM-1 and blaCTX-M-15-Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 62(5), article number: e02642-17. (10.1128/AAC.02642-17)
• Carretto, E.et al. 2018. Clinical validation of sensitest colistin, a broth microdilution-based method to evaluate colistin MICs. Journal of Clinical Microbiology 56(4), article number: e01523-17. (10.1128/JCM.01523-17)
• Nadimpalli, M.et al. 2018. Combating global antibiotic resistance: emerging one health concerns in lower- and middle-income countries. Clinical Infectious Diseases 66(6), pp. 963-969. (10.1093/cid/cix879)
• Niumsup, P. R.et al. 2018. Prevalence and risk factors for intestinal carriage of CTX-M-type ESBLs in Enterobacteriaceae from a Thai community. European Journal of Clinical Microbiology and Infectious Diseases 37(1), pp. 69-75. (10.1007/s10096-017-3102-9)
• Shen, Y.et al. 2018. Heterogeneous and flexible transmission of mcr-1 in hospital-associated escherichia coli. mBio 9(4), article number: e00943-18. (10.1128/mBio.00943-18)

2017

• Djoko, K. Y.et al. 2017. Copper ions and coordination complexes as novel carbapenem adjuvants. Antimicrobial Agents and Chemotherapy 61(12), article number: AAC.02280-17. (10.1128/AAC.02280-17)
• Yin, W.et al. 2017. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. mBio 8(3), pp. e00543-17. (10.1128/mBio.00543-17)
• Tian, G.et al. 2017. MCR-1-producing Klebsiella pneumoniae outbreak in China. Lancet Infectious Diseases 17(6), pp. 577. (10.1016/S1473-3099(17)30266-9)
• Yang, Q. and Walsh, T. 2017. Toxin-antitoxin systems and their role in disseminating and maintaining antimicrobial resistance. FEMS Microbiology Reviews 41(3), pp. 343-353. (10.1093/femsre/fux006)
• Zhang, R.et al. 2017. Presence of VIM-positive pseudomonas species in chickens and their surrounding environment. Antimicrobial Agents and Chemotherapy 61(7), article number: e00167-17. (10.1128/AAC.00167-17)
• Lei, L.et al. 2017. mcr-1 in Enterobacteriaceae from Companion Animals,Beijing, China, 2012–2016. Emerging Infectious Diseases 23(4), pp. 710-711. (10.3201/eid2304.161732)
• Wang, Y.et al. 2017. Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1 -positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study. The Lancet Infectious Diseases 17(4), pp. 390-199. (10.1016/S1473-3099(16)30527-8)
• Liu, Z.et al. 2017. Plasmid-mediated novel blaNDM-17 gene encoding a Carbapenemase with enhanced activity in a sequence type 48 Escherichia coli strain. Antimicrobial Agents and Chemotherapy 61(5), article number: e02233-16. (10.1128/AAC.02233-16)
• Chen, X.et al. 2017. Detection and dissemination of the colistin resistance gene, mcr-1, from isolates and faecal samples in China. Journal of Medical Microbiology 66(2), pp. 119-125. (10.1099/jmm.0.000425)
• Wang, Y.et al. 2017. Comprehensive resistome analysis reveals the prevalence of NDM and MCR-1 in Chinese poultry production. Nature Microbiology 2, article number: 16260. (10.1038/nmicrobiol.2016.260)
• Grundmann, H.et al. 2017. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infectious Diseases 17(2), pp. 153-163. (10.1016/S1473-3099(16)30257-2)
• Hancock, S. J.et al. 2017. Identification of IncA/C plasmid replication and maintenance genes and development of a plasmid multilocus sequence typing scheme. Antimicrobial Agents and Chemotherapy 61(2), article number: e01740-16. (10.1128/AAC.01740-16)
• Hinchliffe, P.et al. 2017. Insights into the mechanistic basis of plasmid-mediated colistin resistance from crystal structures of the catalytic domain of MCR-1. Scientific Reports 7, article number: 39392. (10.1038/srep39392)
• Coates, K.et al. 2017. 1.12 A˚ resolution crystal structure of the catalytic domain of the plasmid-mediated colistin resistance determinant MCR-2. Acta Crystallographica Section F Structural Biology Communications 73(8), pp. 443-449. (10.1107/S2053230X17009669)

2016

• Walsh, T. R. and Wu, Y. 2016. China bans colistin as a feed additive for animals. The Lancet Infectious Diseases 16(10), pp. 1102-1103. (10.1016/S1473-3099(16)30329-2)
• Wailan, A. M.et al. 2016. Mechanisms involved in acquisition of blaNDM genes by IncA/C2 and IncFIIY plasmids. Antimicrobial Agents and Chemotherapy 60(7), pp. 4082-4088. (10.1128/AAC.00368-16)
• Yang, Q. E.et al. 2016. Complete sequence of the FII plasmid p42-2, carrying blaCTX-M-55, oqxAB, fosA3, and floR from Escherichia coli. Antimicrobial Agents and Chemotherapy 60(7), pp. 4336-4338. (10.1128/AAC.00475-16)
• Tyrrell, J. M.et al. 2016. Genetic & virulence profiling of ESBL-positive E. coli from nosocomial & veterinary sources. Veterinary Microbiology 186, pp. 37-43. (10.1016/j.vetmic.2016.02.007)
• Walsh, T. R., Efthimiou, J. and Dréno, B. 2016. Systematic review of antibiotic resistance in acne: an increasing topical and oral threat. The Lancet Infectious Diseases 16(3), pp. e23-e33. (10.1016/S1473-3099(15)00527-7)
• Liu, Y.et al. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet Infectious Diseases 16(2), pp. 161-168. (10.1016/S1473-3099(15)00424-7)
• Chen, D.et al. 2016. Infection by and dissemination of NDM-5-producing Escherichia coli in China. Journal of Antimicrobial Chemotherapy 71(2), pp. 563-565. (10.1093/jac/dkv352)

2015

• Qamar, M. U.et al. 2015. Prevalence and clinical burden of NDM-1 positive infections in pediatric and neonatal patients in pakistan. The Pediatric Infectious Disease Journal 34(4), pp. 452-454. (10.1097/INF.0000000000000582)
• Zowawi, H. M.et al. 2015. Molecular epidemiology of carbapenem-resistant acinetobacter baumannii isolates in the Gulf cooperation council states: dominance of OXA-23-type producers. Journal of Clinical Microbiology 53(3), pp. 896-903. (10.1128/JCM.02784-14)
• Jones, L. S.et al. 2015. Characterization of plasmids in extensively drug-resistant acinetobacter strains isolated in India and Pakistan. Antimicrobial Agents and Chemotherapy 59(2), pp. 923-929. (10.1128/AAC.03242-14)

2014

• Ferguson, E. L.et al. 2014. Dextrin-Colistin conjugates as a model bioresponsive treatment for multidrug resistant bacterial infections. Molecular Pharmaceutics 11(12), pp. 4437-4447. (10.1021/mp500584u)
• Jones, L. S.et al. 2014. Plasmid carriage of blaNDM-1 in clinical Acinetobacter baumannii isolates from India. Antimicrobial Agents and Chemotherapy 58(7), pp. 4211-4213. (10.1128/AAC.02500-14)
• King, A. M.et al. 2014. Aspergillomarasmine A overcomes metallo-beta-lactamase antibiotic resistance. Nature 510(7506), pp. 503-506. (10.1038/nature13445)
• Zowawi, H. M.et al. 2014. Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.. Antimicrobial Agents and Chemotherapy 58(6), pp. 3085-3090. (10.1128/AAC.02050-13)
• Petty, N. K.et al. 2014. Global dissemination of a multidrug resistant Escherichia coli clone. Proceedings of the National Academy of Sciences of the United States of America 111(15), pp. 5694-5699. (10.1073/pnas.1322678111)
• Gould, I. M.et al. 2014. MDRO Beijing Consensus Meeting Report: Global burden of multidrug-resistant organisms' current antimicrobial resistance problems in Asia-Pacific. Journal of Antimicrobial Resistance 2(1), pp. 7-9. (10.1016/j.jgar.2013.10.005)

2013

• Edelstein, M. V.et al. 2013. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study. The Lancet Infectious Diseases 13(10), pp. 867-876. (10.1016/S1473-3099(13)70168-3)
• Zowawi, H.et al. 2013. β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clinical Microbiology Reviews 26(3), pp. 361-380. (10.1128/CMR.00096-12)

2012

• Khan, S.et al. 2012. Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibiotics. Antimicrobial Agents and Chemotherapy 56(10), pp. 5134-5141. (10.1128/AAC.00525-12)
• Darley, E.et al. 2012. NDM-1 polymicrobial infections including 'Vibrio cholerae'. The Lancet 380(9850), pp. 1358. (10.1016/S0140-6736(12)60911-8)
• El Salabi, A., Walsh, T. R. and Chouchani, C. 2012. Extended spectrum β -lactamases, carbapenemases and mobile genetic elements responsible for antibiotics resistance in Gram-negative bacteria. Critical Reviews in Microbiology 39(2), pp. 113-122. (10.3109/1040841X.2012.691870)
• El Salabi, A.et al. 2012. Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrobial Agents and Chemotherapy 56(5), pp. 2241-2245. (10.1128/AAC.05640-11)
• Giske, C. G.et al. 2012. Diverse sequence types of klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom. Antimicrobial Agents and Chemotherapy 56(5), pp. 2735-2738. (10.1128/AAC.06142-11)
• Toleman, M. A. H.et al. 2012. blaNDM-1 is a chimera likely constructed in acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 56(5), pp. 2773-2776. (10.1128/AAC.06297-11)
• Walsh, T. R.et al. 2012. Dissemination of NDM-1 - authors' reply [Letter]. The Lancet Infectious Diseases 12(2), pp. 101-102. (10.1016/S1473-3099(11)70372-3)

2011

• Toleman, M. A. H. and Walsh, T. R. 2011. Combinatorial events of insertion sequences and ICE in Gram-negative bacteria. FEMS Microbiology Reviews 35(5), pp. 912-935. (10.1111/j.1574-6976.2011.00294.x)
• Davey, M. S.et al. 2011. A promising target for treatment of multidrug-resistant bacterial infections [Letter]. Antimicrobial Agents and Chemotherapy 55(7), pp. 3635-3636. (10.1128/AAC.00382-11)
• Walsh, T. R.et al. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. The Lancet Infectious Diseases 11(5), pp. 355-362. (10.1016/S1473-3099(11)70059-7)
• Livermore, D. M.et al. 2011. Balkan NDM-1: Escape or transplant? [Correspondence]. The Lancet Infectious Diseases 11(3), pp. 164. (10.1016/S1473-3099(11)70048-2)
• Walsh, T. R. and Toleman, M. A. H. 2011. The new medical challenge: why NDM-1? Why Indian?. Expert Review of Anti-infective Therapy 9(2), pp. 137-141. (10.1586/eri.10.159)
• Samuelsen, ?.et al. 2011. Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clinical Microbiology and Infection 17(12), pp. 1811-1816. (10.1111/j.1469-0691.2011.03532.x)
• Mata, C.et al. 2011. Association of blaDHA-1 and qnrB genes carried by broad-host-range plasmids among isolates of Enterobacteriaceae at a Spanish hospital. Clinical Microbiology and Infection 17(10), pp. 1514-1517. (10.1111/j.1469-0691.2011.03539.x)
• Nordmann, P.et al. 2011. Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?. Journal of Antimicrobial Chemotherapy 66(4), pp. 689-692. (10.1093/jac/dkq520)
• Mata, C.et al. 2011. Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis. Journal of Antimicrobial Chemotherapy 66(10), pp. 2266-2270. (10.1093/jac/dkr286)
• Walsh, T. R. and Toleman, M. A. H. 2011. The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response. Journal of Antimicrobial Chemotherapy 67(1), pp. 1-3. (10.1093/jac/dkr378)
• Mata, C.et al. 2011. Plasmid typing and genetic context of AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999-2007. Journal of Antimicrobial Chemotherapy 67(1), pp. 115-122. (10.1093/jac/dkr412)
• Sidjabat, H.et al. 2011. Carbapenem resistance in "Klebsiella pneumoniae" due to the New Delhi Metallo-β-lactamase. Clinical Infectious Diseases 52(4), pp. 481-484. (10.1093/cid/ciq178)

2010

• Davey, M. S.et al. 2010. Innate crosstalk of gamma delta T cells, neutrophils and monocytes in response to HMB-PP producing bacteria [Abstract]. Immunology 131, pp. 63-63. (10.1111/j.1365-2567.2010.03390.x)
• Hammerum, A. M.et al. 2010. Global spread of New Delhi metallo-β-lactamase 1. The Lancet Infectious Diseases 10(12), pp. 829-830. (10.1016/S1473-3099(10)70276-0)
• Kumarasamy, K. K.et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. The Lancet Infectious Diseases 10(9), pp. 597-602. (10.1016/S1473-3099(10)70143-2)
• Hawrani, A.et al. 2010. Thermodynamics of RTA3 peptide binding to membranes and consequences for antimicrobial activity. Biochimica et Biophysica Acta - Biomembranes 1798(6), pp. 1254-1262. (10.1016/j.bbamem.2010.03.017)
• Walsh, T. R.et al. 2010. New Delhi metallo-beta-lactamase 1 [Authors' reply]. The Lancet Infectious Diseases 10(11), pp. 752-754. (10.1016/S1473-3099(10)70245-0)
• Ferreira, S.et al. 2010. Carriage of qnrA1 and qnrB2, blaCTX-M15, and complex class 1 integron in a clinical multiresistant Citrobacter freundii isolate. Diagnostic Microbiology and Infectious Disease 67(2), pp. 188-190. (10.1016/j.diagmicrobio.2010.01.003)
• Ferreira, S.et al. 2010. First description of klebsiella pneumoniae clinical isolates carrying both qnrA and qnrB genes in Portugal. International Journal of Antimicrobial Agents 35(6), pp. 584-586. (10.1016/j.ijantimicag.2010.01.019)
• Wootton, M.et al. 2010. Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins. Journal of Antimicrobial Chemotherapy 65(1), pp. 79-81. (10.1093/jac/dkp404)
• Toleman, M. A. H., Walsh, T. R. and Call, D. R. 2010. ISCR elements are key players in IncA/C plasmid evolution [Letter]. Antimicrobial Agents and Chemotherapy 54(8), pp. 3534. (10.1128/AAC.00383-10)
• Nordmann, P.et al. 2010. How to detect NDM-1 producers. Journal of Clinical Microbiology 49(2), pp. 718-721. (10.1128/JCM.01773-10)

2009

• Yong, D.et al. 2009. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in klebsiella pneumoniae sequence Type 14 from India. Antimicrobial Agents and Chemotherapy 53(12), pp. 5046-5054. (10.1128/AAC.00774-09)
• El Salabi, A.et al. 2009. First report of the metallo-β-lactamase SPM-1 in Europe. Antimicrobial Agents and Chemotherapy 54(1), pp. 582. (10.1128/AAC.00719-09)
• Wootton, M.et al. 2009. Evaluation of the Effectiveness of Common Hospital Hand Disinfectants Against Methicillin-Resistant Staphylococcus aureus, Glycopeptide-Intermediates, S aureus, and Heterogeneous Glycopeptide-Intermediate S. aureus. Infection Control and Hospital Epidemiology 30(3), pp. 226-232. (10.1086/595691)
• Patzer, J. A.et al. 2009. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006. Journal of Antimicrobial Chemotherapy 63(2), pp. 269-273. (10.1093/jac/dkn512)
• Giske, C. G.et al. 2009. Redefining extended-spectrum β-lactamases: balancing science and clinical need - authors' response. Journal of Antimicrobial Chemotherapy 64(1), pp. 213-215. (10.1093/jac/dkp143)
• Poirel, L.et al. 2009. ISCR2, another vehicle for blaVEB gene acquisition. Antimicrobial Agents and Chemotherapy 53(11), pp. 4940-4943. (10.1128/AAC.00414-09)
• Samuelsen, O.et al. 2009. Molecular epidemiology of metallo-β-lactamase-producing pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrobial Agents and Chemotherapy 54(1), pp. 346-352. (10.1128/AAC.00824-09)
• Aktas, Z.et al. 2009. CTX-M-15 carried on Incn-type plasmids in Klebsiella pneumoniae. Turkiye Klinikleri Journal of Medical Sciences 29(6), pp. 1355-1364.

2008

• Hawrani, A.et al. 2008. Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides. Journal of Biological Chemistry 283(27), pp. 18636-18645. (10.1074/jbc.M709154200)
• Haldorsen, B.et al. 2008. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC. Journal of Antimicrobial Chemotherapy 62(4), pp. 694-702. (10.1093/jac/dkn257)
• Giske, C. G.et al. 2008. Redefining extended-spectrum β-lactamases: balancing science and clinical need. Journal of Antimicrobial Chemotherapy 63(1), pp. 1-4. (10.1093/jac/dkn444)
• Samuelsen, O.et al. 2008. Kinetic characterization of VIM-7, a divergent member of the VIM metallo-β-lactamase family. Antimicrobial Agents and Chemotherapy 52(8), pp. 2905-2908. (10.1128/AAC.00166-08)
• Toleman, M. A. H. and Walsh, T. R. 2008. Evolution of the ISCR3 group of ISCR elements. Antimicrobial Agents and Chemotherapy 52(10), pp. 3789-3791. (10.1128/AAC.00479-08)
• Li, H., Walsh, T. R. and Toleman, M. A. H. 2008. Molecular analysis of the sequences surrounding blaOXA-45 reveals acquisition of this gene by pseudomonas aeruginosa via a novel ISCR element, ISCR5. Antimicrobial Agents and Chemotherapy 53(3), pp. 1248-1251. (10.1128/AAC.00480-08)
• Samuelsen, O.et al. 2008. The first metallo-β-lactamase identified in Norway is associated with a TniC-like transposon in a pseudomonas aeruginosa isolate of sequence type 233 imported from Ghana. Antimicrobial Agents and Chemotherapy 53(1), pp. 331-332. (10.1128/AAC.00785-08)
• Li, H.et al. 2008. Complete sequence of p07-406, a 24,179-base-pair plasmid harboring the blaVIM-7 metallo-β-lactamase gene in a pseudomonas aeruginosa isolate from the United States. Antimicrobial Agents and Chemotherapy 52(9), pp. 3099-3105. (10.1128/AAC.01093-07)
• Yusof, A.et al. 2008. Evaluation of a new etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate staphylococcus aureus (GISA), in particular, heterogeneous GISA. Journal of Clinical Microbiology 46(9), pp. 3042-3047. (10.1128/JCM.00265-08)
• Gonullu, N.et al. 2008. Dissemination of CTX-M-15 β-lactamase genes carried on inc FI and FII plasmids among clinical isolates of escherichia coli in a university hospital in Istanbul, Turkey. Journal of Clinical Microbiology 46(3), pp. 1110-1112. (10.1128/JCM.01974-07)
• Walsh, T. R. 2008. Clinically significant carbapenemases: an update. Current Opinion in Infectious Diseases 21(4), pp. 367-371. (10.1097/QCO.0b013e328303670b)

2007

• Toleman, M. . A. H.et al. 2007. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerging infectious diseases 13, pp. 559-65.

2006

• Murphy, T. A.et al. 2006. Crystal structure of Pseudomonas aeruginosa SPM-1 provides insights into variable zinc affinity of metallo-beta-lactamases. Journal of Molecular Biology 357(3), pp. 890-903. (10.1016/j.jmb.2006.01.003)

2005

• Simm, A. M.et al. 2005. Bulgecin A: a novel inhibitor of binuclear metallo-beta-lactamases. Biochemical Journal 387(3), pp. 585-590. (10.1042/BJ20041542)

2002

• Simm, A. M.et al. 2002. Characterization of monomeric L1 metallo-beta -lactamase and the role of the N-terminal extension in negative cooperativity and antibiotic hydrolysis. Journal of Biological Chemistry 277(27), pp. 24744-24752. (10.1074/jbc.M201524200)